Cell-cycle and apoptosis related and proteomics-based signaling pathways of human hepatoma Huh-7 cells treated by three currently used multi-RTK inhibitors.

Ren, Xuejiao; Zhang, Qingning; Guo, Wenyan; Wang, Lan; Wu, Tao; Zhang, Wei; Liu, Ming; Kong, Dezhi

Ren, Xuejiao; Zhang, Qingning; Guo, Wenyan; Wang, Lan; Wu, Tao; Zhang, Wei; Liu, Ming; Kong, Dezhi.

Afiliação

Ren X; Department of Radiotherapy, Third Hospital of Hebei Medical University, Shijiazhuang, China.
Zhang Q; Department of Radiotherapy, Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Guo W; Department of Pharmacology of Chinese Materia Medica, School of Chinese Integrative Medicine, Hebei Medical University, Shijiazhuang, China.
Wang L; Department of Pharmacology of Chinese Materia Medica, School of Chinese Integrative Medicine, Hebei Medical University, Shijiazhuang, China.
Wu T; Department of Radiotherapy, Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Zhang W; Department of Radiotherapy, Third Hospital of Hebei Medical University, Shijiazhuang, China.
Liu M; Department of Pharmacology of Chinese Materia Medica, School of Chinese Integrative Medicine, Hebei Medical University, Shijiazhuang, China.
Kong D; Department of Radiotherapy, Third Hospital of Hebei Medical University, Shijiazhuang, China.

Front Pharmacol ; 13: 944893, 2022.

Article em En | MEDLINE | ID: mdl-36071844

Palavras-chave

Huh-7 cells; cell apoptosis; cell cycle; lenvatinib; proteomics; regorafenib; signal pathway; sorafenib

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Pharmacol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google